Coverage dated December 18, 2025 to December 19, 2025
Trump announces lower drug price deals with 9 pharmaceutical companies
Headline from KOB 4
U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will now charge Medicaid what they charge in other de…
KOB 4's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will now charge Medicaid what they charge in other de…
In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.
President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their medications at lower prices in a "Most Favored Nation" program.
Nine pharmaceutical companies agreed to slash prices on some of their drugs for Medicaid recipients and people who pay with cash as part of a new deal with the Trump administration.
U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.Pharmaceutical companies Amgen, Bristol
President Donald Trump and nine major pharmaceutical companies today announced deals that will slash the prices of their medicines for the government’s Medicaid program and for cash payers, in his latest bid to align U.S. costs with those in other wealthy nations.
